Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Logo for

J. Neurosci. 24 (27): 6133-6143

Copyright © 2004 by the Society for Neuroscience.

Development/Plasticity/Repair

Dopamine, through the Extracellular Signal-Regulated Kinase Pathway, Downregulates CD4+CD25+ Regulatory T-Cell Activity: Implications for Neurodegeneration

Jonathan Kipnis, Michal Cardon, Hila Avidan, Gil M. Lewitus, Sharon Mordechay, Asya Rolls, Yael Shani, , and Michal Schwartz

Department of Neurobiology, The Weizmann Institute of Science, 76100 Rehovot, Israel

Abstract: Fighting off neuronal degeneration requires a well controlled T-cell response against self-antigens residing in sites of the CNS damage. The ability to evoke this response is normally suppressed by naturally occurring CD4+CD25+ regulatory T-cells (Treg). No physiological compound that controls Treg activity has yet been identified. Here, we show that dopamine, acting via type 1 dopamine receptors (found here to be preferentially expressed by Treg), reduces the suppressive activity and the adhesive and migratory abilities of Treg. Treg activity was correlated with activation of the ERK1/2 (extracellular signal-regulated kinase 1/2) signaling pathway. Systemic injection of dopamine or an agonist of its type 1 receptors significantly enhanced, via a T-cell-dependent mechanism, protection against neuronal death after CNS mechanical and biochemical injury. These findings shed light on the physiological mechanisms controlling Treg and might open the way to novel therapeutic strategies for downregulating Treg activity (e.g., in neuronal degeneration) or for strengthening it (in autoimmune diseases).

Key Words: CD4+CD25+ regulatory T-cells • neurotransmitters • dopamine • dopamine receptors • ERK1/2 • autoimmune response • neuroprotection • neurodegeneration • CNS

Received for publication Feb 19, 2004. Revision received May 28, 2004. Accepted for publication May 28, 2004.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Docosahexaenoic acid reduces suppressive and migratory functions of CD4CD25 regulatory T-cells.
A. Yessoufou, A. Ple, K. Moutairou, A. Hichami, and N. A. Khan (2009)
J. Lipid Res. 50, 2377-2388
   Abstract »    Full Text »    PDF »
Response:Resistance of naturally occurring regulatory T cells toward oxidative stress: possible link with intracellular catecholamine content and implications for cancer therapy.
D. Mougiakakos, C. C. Johansson, and R. Kiessling (2009)
Blood 114, 488-489
   Full Text »    PDF »
TOTAL CHOLESTEROL AND THE RISK OF PARKINSON DISEASE.
L. Mascitelli, F. Pezzetta, M. R. Goldstein, and J. Tuomilehto (2009)
Neurology 72, 860-861
   Full Text »    PDF »
Increased Regulatory versus Effector T Cell Development Is Associated with Thymus Atrophy in Mouse Models of Multiple Myeloma.
A. Laronne-Bar-On, D. Zipori, and N. Haran-Ghera (2008)
J. Immunol. 181, 3714-3724
   Abstract »    Full Text »    PDF »
Neuroprotective Immunity: T Cell-Derived Glutamate Endows Astrocytes with a Neuroprotective Phenotype.
S. K. Garg, R. Banerjee, and J. Kipnis (2008)
J. Immunol. 180, 3866-3873
   Abstract »    Full Text »    PDF »
Bacterial DNA Confers Neuroprotection after Optic Nerve Injury by Suppressing CD4+CD25+ Regulatory T-Cell Activity.
T. V. Johnson, C. B. Camras, and J. Kipnis (2007)
Invest. Ophthalmol. Vis. Sci. 48, 3441-3449
   Abstract »    Full Text »    PDF »
A Novel Immune-Based Therapy for Stroke Induces Neuroprotection and Supports Neurogenesis.
Y. Ziv, A. Finkelstein, Y. Geffen, J. Kipnis, I. Smirnov, S. Shpilman, I. Vertkin, M. Kimron, A. Lange, T. Hecht, et al. (2007)
Stroke 38, 774-782
   Abstract »    Full Text »    PDF »
Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop.
M. Cosentino, A. M. Fietta, M. Ferrari, E. Rasini, R. Bombelli, E. Carcano, F. Saporiti, F. Meloni, F. Marino, and S. Lecchini (2007)
Blood 109, 632-642
   Abstract »    Full Text »    PDF »
Cutting Edge: Stimulation of Dopamine D4 Receptors Induce T Cell Quiescence by Up-Regulating Kruppel-Like Factor-2 Expression through Inhibition of ERK1/ERK2 Phosphorylation.
C. Sarkar, S. Das, D. Chakroborty, U. R. Chowdhury, B. Basu, P. S. Dasgupta, and S. Basu (2006)
J. Immunol. 177, 7525-7529
   Abstract »    Full Text »    PDF »
Dual effect of CD4+CD25+ regulatory T cells in neurodegeneration: A dialogue with microglia.
J. Kipnis, H. Avidan, R. R. Caspi, and M. Schwartz (2004)
PNAS 101, 14663-14669
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882